GST101
/ Genuine Seed Therapeutics
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 09, 2026
GST101-001: GST101 in Participants With RAS-Mutant Advanced Solid Tumors
(clinicaltrials.gov)
- P1/2 | N=172 | Not yet recruiting | Sponsor: Genuine Seed Therapeutics (Zhuhai) Co., Ltd.
New P1/2 trial • Colorectal Cancer • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1